ClearFlow: Active Clearance Technology
Support
  • Blog
  • About
  • Press
  • FAQ
  • Resources
  • Education
  • Sales
  • Cost Calculator
  • Contact
  • Blog
  • About
  • Press
  • FAQ
  • Resources
  • Education
  • Sales
  • Cost Calculator
  • Contact
  • Support

ClearFlow: Active Clearance Technology

  • ChallengeRetained Blood Syndrome
  • SolutionPleuraFlow® ACT
  • MissionA New Standard

Press 2007

Cleveland Clinic & Medical Device Innovations, LLC, Form Clear Catheter Solutions LLC

by James Herlofsky
Read More

Oregon incubator, Clinic form joint ventures

by James Herlofsky
Read More

Recent Press

  • PleuraFlow Shown to Enable Improved Outcomes for Cardiac Surgery Patients in New Clinical Study Results
  • New Published Clinical Trial Results Confirm that PleuraFlow Enables Improved Quality and Cost of Care for Cardiac Surgery Patients
  • ClearFlow Announces Positive Randomized Controlled Trial Results and Inclusion in ERAS Guideline Recommendations
  • ERAS Cardiac Surgery Featured at Dedicated Session at European Association for Cardio-Thoracic Surgery in Milan
  • ClearFlow Awarded Chest Drainage Products Agreement with Premier

Archives

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2007

Press Contact:

Paul Williams
MediaLine Communications
(949) 916-6880
paul@medialinecommunications.com

or

James Herlofsky, Marketing Manager
ClearFlow, Inc.
(310) 569-5604
jherlofsky@clearflow.com

ClearFlow: Active Clearance Technology

  • ChallengeRetained Blood Syndrome
  • SolutionPleuraFlow® ACT
  • MissionA New Standard
  • Blog
  • About
  • Press
  • FAQ
  • Resources
  • Education
  • Sales
  • Cost Calculator
  • Contact
Clinical References| Terms of Use| PleuraFlow ACT System Indications of Use|

PleuraFlow® ACT® is not indicated as a therapeutic device.

ClearFlow’s PleuraFlow® Active Clearance Technology® and many of its features are protected by a comprehensive family of both US and foreign patents and patent applications in major markets throughout the world, including Canada, Australia and the European Community. In the United States, PleuraFlow® products are protected by US Patent Nos. 7,854,728, 7,951,243, 8,246,752, 8,048,233, 8,388,759, 8,702,662 and 8,951,355. The PleuraFlow® product is the first device of its kind to effectively and reproducibly clear obstructing material from chest tubes without compromising the sterile field, and thus patient recovery. It is the only FDA 510(k) cleared device of its kind for this indication. ClearFlow’s patent portfolio has been tailored not only to protect this product, but also to provide protection around this new market segment thus presenting a barrier to entry for competing products.

Website by Bloom Creative